July « 2022 « Science and Enterprise

Synthetic Bio Microbiome Biotech Gains $15M in Seed Funds

By Alan, on July 19th, 2022%

A developer of therapies produced with synthetic biology for diseases linked to microbes in the gut is raising $15 million in seed financing. . . . → Read More: Synthetic Bio Microbiome Biotech Gains $15M in Seed Funds

Impress vs competitors, why is it the best option?

By Alan, on July 19th, 2022%

Impress offers patients treatment for complex cases such as overcrowding, abnormal spacing, and bite malalignment, as well as diagnostics like X-Rays before treatment. . . . → Read More: Impress vs competitors, why is it the best option?

Surgical Robotics Company Raises $55M in Early Funds

By Alan, on July 18th, 2022%

A developer of robotic systems for cataract and other eye surgeries is raising $55 million in its first venture financing round. . . . → Read More: Surgical Robotics Company Raises $55M in Early Funds

Four Issues Holding Back Small Businesses

By Alan, on July 18th, 2022%

Do you feel as though your company is being held back? If so, then you are not alone. . . . → Read More: Four Issues Holding Back Small Businesses

Infographic – US Biotech Investments Stay Strong

By Alan, on July 16th, 2022%

The first half half of 2022 shows venture investments in U.S. biotechnology start-ups cooled from the blistering pace of last year, but biotech remains a robust sector. . . . → Read More: Infographic – US Biotech Investments Stay Strong

NIH Funding Engineered Phage Screening Device

By Alan, on July 15th, 2022%

National Institutes of Health is funding initial development of a microfluidic device that tests engineered viruses for their ability to kill disease-causing bacteria. . . . → Read More: NIH Funding Engineered Phage Screening Device

Precision Protein Design Start-Up Gains $40M in Early Funds

By Alan, on July 14th, 2022%

A start-up company designing and testing precise proteins within live animals to speed creation of new therapeutics is raising $40 million in its first venture round. . . . → Read More: Precision Protein Design Start-Up Gains $40M in Early Funds

Biotechs Explore Gut-Brain Axis for Mental Health

By Alan, on July 13th, 2022%

Two biotechnology companies are advancing basic research findings connecting gut microbes with the brain to develop new therapies for neurological disorders. . . . → Read More: Biotechs Explore Gut-Brain Axis for Mental Health

Trial Begins of Precise Gene Editing for Heart Disease

By Alan, on July 12th, 2022%

A clinical trial is underway evaluating a precise form of Crispr gene editing as a one-time therapy for an inherited form of heart disease. . . . → Read More: Trial Begins of Precise Gene Editing for Heart Disease

Diabetes Cell Therapy Biotech Acquired in $320M Deal

By Alan, on July 11th, 2022%

A developer of therapies derived from stem cells to replace malfunctioning islet cells in people with type 1 diabetes was acquired by Vertex Pharmaceuticals. . . . → Read More: Diabetes Cell Therapy Biotech Acquired in $320M Deal

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise